These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15858196)

  • 21. Assessing the introduction of universal varicella vaccination in the Netherlands.
    Boot HJ; de Melker HE; Stolk EA; de Wit GA; Kimman TG
    Vaccine; 2006 Sep; 24(37-39):6288-99. PubMed ID: 16790302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.
    Carville KS; Riddell MA; Kelly HA
    Vaccine; 2010 Mar; 28(13):2532-8. PubMed ID: 20117265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chickenpox complications in Saudi Arabia: Is it time for routine varicella vaccination?
    Almuneef M; Memish ZA; Balkhy HH; Alotaibi B; Helmy M
    Int J Infect Dis; 2006 Mar; 10(2):156-61. PubMed ID: 16260166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Get off the fence--vaccinate against varicella.
    Fiechtner HB
    S D J Med; 1999 Nov; 52(11):421. PubMed ID: 10586646
    [No Abstract]   [Full Text] [Related]  

  • 25. Is Europe ready to embrace a policy of universal varicella vaccination?
    Ramet J; Weil-Olivier C; Sedlak W;
    Int J Clin Pract; 2005 Nov; 59(11):1326-33. PubMed ID: 16236088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella vaccination in Japan, South Korea, and Europe.
    Sadzot-Delvaux C; Rentier B; Wutzler P; Asano Y; Suga S; Yoshikawa T; Plotkin SA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S185-90. PubMed ID: 18419395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.
    Tseng HF; Tan HF; Chang CK
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1450-8. PubMed ID: 16610647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.
    Brisson M; Edmunds WJ; Gay NJ
    J Med Virol; 2003; 70 Suppl 1():S31-7. PubMed ID: 12627484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.
    Grose C
    J Clin Virol; 2005 Jun; 33(2):89-95; discussion 96-8. PubMed ID: 15911422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].
    Knuf M; Neiss A; Wutzler P
    Klin Padiatr; 2006; 218(4):203-12. PubMed ID: 16819701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Younger age at vaccination may increase risk of varicella vaccine failure.
    Galil K; Fair E; Mountcastle N; Britz P; Seward J
    J Infect Dis; 2002 Jul; 186(1):102-5. PubMed ID: 12089668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.
    Chaves SS; Zhang J; Civen R; Watson BM; Carbajal T; Perella D; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S127-31. PubMed ID: 18419385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An economic evaluation of varicella vaccination in Italian adolescents.
    Thiry N; Beutels P; Tancredi F; Romanò L; Zanetti A; Bonanni P; Gabutti G; Van Damme P
    Vaccine; 2004 Sep; 22(27-28):3546-62. PubMed ID: 15315834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Varicella: do we have to change vaccine recommendations?].
    Gaudelus J
    Arch Pediatr; 2009 Jun; 16(6):929-31. PubMed ID: 19541225
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do the benefits of varicella vaccination outweigh the long-term risks? A decision-analytic model for policymakers and pediatricians.
    Rothberg M; Bennish ML; Kao JS; Wong JB
    Clin Infect Dis; 2002 Apr; 34(7):885-94. PubMed ID: 11880952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan.
    Tseng HF; Tan HF; Chang CK
    Vaccine; 2006 Jun; 24(25):5341-8. PubMed ID: 16713038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An economic analysis of the universal varicella vaccination program in the United States.
    Zhou F; Ortega-Sanchez IR; Guris D; Shefer A; Lieu T; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S156-64. PubMed ID: 18419391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling the impact of varicella vaccination on varicella and zoster.
    Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
    Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.